Inhibix Antiviral Of South Carolina LLC is categorized under Noncommercial Research Organizations in Columbia, SC .
Inhibix Antiviral Of South Carolina LLC was established in 0, and today employs 1 to 4, earning $0 to $49.999 per year. This is a Noncommercial Research Organizations business, which does work in the B2B market, and is classified as a Noncommercial Research Organizations, under code number 541720 by the NAICS.
If you are seeking more information, feel free to contact Gregory S Grice at the company’s single location by writing to 1334 Sumter St, Columbia, South Carolina SC 29201 or by phoning (251) 209-6878. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Inhibix Antiviral Of South Carolina LLC |
| Contact Person: | Gregory S Grice |
| Address: | 1334 Sumter St, Columbia, South Carolina 29201 |
| Phone Number: | (251) 209-6878 |
| Annual Revenue (USD): | $0 to $49.999 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Noncommercial Research Organizations |
| SIC Code: | 8733 |
| NAICS Code: | 541720 |
| Share This Business: |
Inhibix Antiviral Of South Carolina LLC was started in 0 to provide professional Noncommercial Research Organizations under the SIC code 8733 and NAICS code 541720. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $0 to $49.999 per annum.
Feel free to contact Gregory S Grice for inquiries that concern Inhibix Antiviral Of South Carolina LLC by calling the company number (251) 209-6878, as your correspondence is most welcome. Additionally, the physical location of the single location of Inhibix Antiviral Of South Carolina LLC can be found at the coordinates as well as the street address 1334 Sumter St in Columbia, South Carolina 29201.
For its online presence, you may visit Inhibix Antiviral Of South Carolina LLC’s website at and engage with its social media outlets through on Twitter and on Facebook.